(Q44374779)

2 December 2017

title

Effect of agomelatine in the chronic mild stress model of depression in the rat. (English)

1 reference

2 December 2017

1

Mariusz Papp

1 reference

2 December 2017

2

Piotr Gruca

1 reference

2 December 2017

4

Elisabeth Mocaër

1 reference

2 December 2017

Pierre-Alain Boyer

3

1 reference

2 December 2017

language of work or name

English

0 references

publication date

17 October 2002

1 reference

2 December 2017

published in

Neuropsychopharmacology

1 reference

2 December 2017

volume

28

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

694-703

1 reference

Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS).

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Changes in sleep architecture following chronic mild stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Characterisation of human melatonin mt(1) and MT(2) receptors by CRE-luciferase reporter assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Dim light melatonin onset and circadian temperature during a constant routine in hypersomnic winter depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Diurnal variation in the effect of chronic mild stress on sucrose intake and preference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Antidepressant and circadian phase-shifting effects of light

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Maprotiline, nomifensine, mianserin, zimelidine: a review of antidepressant efficacy in in-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Anxiety and affective style: role of prefrontal cortex and amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Entrainment of rat circadian rhythms by the melatonin agonist S-20098 requires intact suprachiasmatic nuclei but not the pineal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Neuroendocrine aspects of primary endogenous depression. XV: Mathematical modeling of nocturnal melatonin secretion in major depressives and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Psychotropic effects of ritanserin, a selective S2 antagonist: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Comparative effects of a melatonin agonist on the circadian system in mice and Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Circadian rhythm mechanisms in affective illness and in antidepressant drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Melatonin analogues as agonists and antagonists in the circadian system and other brain areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Chronic exposure to melatonin receptor agonists does not alter their effects on suprachiasmatic nucleus neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Novel naphthalenic ligands with high affinity for the melatonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

Effect of chronic mild stress on circadian rhythms in the locomotor activity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

7 January 2021

Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

7 January 2021

Effects of melatonin receptor ligands on swim test immobility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

7 January 2021

Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

7 January 2021

Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

7 January 2021

Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

7 January 2021

Morning vs evening light treatment for winter depression. Evidence that the therapeutic effects of light are mediated by circadian phase shifts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

7 January 2021

A comparison of melatonin secretion in depressed patients and normal subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

7 January 2021

A melatonin agonist facilitates circadian resynchronization in old hamsters after abrupt shifts in the light-dark cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300091

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300091

1 reference

2 December 2017

1 reference